Today's Date: April 29, 2024
Xavier Ochsner College of Medicine Announces Founding Dean and Location in Downtown New Orleans at Benson Tower   •   CHOP Study Finds Healthcare Providers Play Crucial Role in Guiding Autistic Adolescents and Their Families into Adulthood   •   Disney Celebrates World Wish Day ® by Granting Over One Hundred Wishes Around the World   •   How artificial intelligence can transform U.S. energy infrastructure with a new report from Argonne and partners   •   RYAM to Suspend Temiscaming High Purity Cellulose Plant Operations for an Indefinite Period   •   Atlanta-based Nonprofit to Host National Law Enforcement Community Engagement Training Conference, May 1-5   •   ICIVICS AND THE WHITE HOUSE HISTORICAL ASSOCIATION LAUNCH "BRIEF THE CHIEF," A NEW DIGITAL GAME SHOWING STUDENTS HOW PRESIDENTS   •   New Perspective closes on more than $200 Million in capital and establishes a programmatic relationship for growth   •   InventHelp Inventor Develops New Religious-Themed Game (BRK-4269)   •   Chegg Announces Appointment of Nathan Schultz as Chief Executive Officer   •   LSB Industries, Inc. Reports Operating Results for the 2024 First Quarter   •   Health-E Commerce® shares 5 ways to use FSA or HSA funds to support women's health   •   20/20 Onsite Launches ‘Vision for Southbridge’ Program to Provide Eye Care to All Southbridge, MA Public Schools   •   Coursera Reports First Quarter 2024 Financial Results   •   USPAACC Announces CelebrASIAN 2024 Procurement + Business Conference, May 29-31, The Hotel at Avalon, Autograph Collection, Alph   •   Statement From Avangrid CEO Pedro Azagra on Groundbreaking of New Array Technologies Manufacturing Facility in New Mexico   •   Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company   •   Plant Vogtle Unit 4 Achieves Commercial Operations   •   Chegg Reports 2024 First Quarter Earnings   •   Ten Pennsylvania Communities Selected to Participate in Community Revitalization Initiative
Bookmark and Share

Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%

NEW BRUNSWICK, N.J. , April 16 /Businesswire/ - Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd year of consecutive increases.

At the new rate, the indicated dividend on an annual basis is $4.96 per share compared to the previous rate of $4.76 per share. The next quarterly dividend is payable on June 4, 2024 to shareholders of record at the close of business on May 21, 2024. The ex-dividend date is May 20, 2024.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.


STORY TAGS: Dividend, United States, North America, Biotechnology, Other Health, Health, Pharmaceutical, Clinical Trials, New Jersey,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News